Published in Medical Letter on the CDC and FDA, September 10th, 2006
Study 1: 99mTc-HYNIC-annexin VSPECT imaging is useful for monitoring the treatment response of acute stroke.
"The first aim of the study was to determine whether 99mTc-HYNIC-annexin V, a marker of cellular stress and apoptosis, can detect ischemic injury in patients with acute stroke. Secondly, we wished to test radiolabeled annexin's ability to monitor therapy in a rodent model of focal ischemic injury. SPECT imaging of patients was performed between one and two hours after intravenous injection of 30 mCi (1,110 MBq) of tracer,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.